EPRX Eupraxia Pharmaceuticals Inc.
Company Analysis
Latest News
🔴 Eupraxia Pharmaceuticals is trading 15.4% down today as it reverses yesterday's technical bounce
Eupraxia Pharmaceuticals is trading at $5.22, down 15.4%, as the stock appears to reverse gains from yesterday's technical bounce. • The decline follows a...
🟢 Eupraxia Pharmaceuticals is trading 5.2% up today on a technical bounce in a risk-on market
Eupraxia Pharmaceuticals is trading 5.2% up today at $6.11 on a technical bounce in a broadly risk-on market. • The stock is staging a recovery following a...
🟢 Eupraxia Pharmaceuticals is trading 6.5% up today as a technical bounce in a risk-on market
Eupraxia Pharmaceuticals is trading at $6.19 (6.5% up) in pre-market, staging a technical bounce following a sharp drop and reversal on July 24, 2026. • The...
🔴 Eupraxia Pharmaceuticals is trading 5.1% down today after reversing a sharp, unexplained pre-market rally
Eupraxia Pharmaceuticals is trading 5.1% down today at $5.98 as it gives back gains from a sharp, unexplained after-hours and pre-market rally. • The stock...
🟢 Eupraxia Pharmaceuticals is trading 15.9% up today with no clear catalyst identified
Eupraxia Pharmaceuticals is trading 15.9% up at $7.30 in pre-market trading, extending a sharp upward move that began during the July 23 after-hours...
🟢 Eupraxia Pharmaceuticals is trading 11.1% up today with no clear catalyst identified
Eupraxia Pharmaceuticals is trading 11.1% up at $7.00 in after-hours trading with no clear catalyst identified for the move. • The stock moved sharply higher...
🟢 Eupraxia Pharmaceuticals Inc. is trading 5.29% up
EPRX is trading at $6.57, up 5.29%.
Eupraxia Reshuffles Its Leadership and Moves to Seattle — But Can a Management Overhaul Justify a 12% Pop for a Pre-Revenue Biotech?
Shares of Eupraxia Pharmaceuticals (EPRX) surged 12.2% in pre-market trading to $7.00, rebounding sharply from a choppy week that saw the stock bounce between...
🟢 Eupraxia Pharmaceuticals is trading 12.2% up today following leadership and operations updates
Eupraxia Pharmaceuticals is trading 12.2% up at $7.00 in pre-market, rebounding from recent weakness and moving back above last week’s range. • The move...
🔴 Eupraxia Pharmaceuticals is trading 5% down today following last week's rebound
Eupraxia Pharmaceuticals is trading 5% down at $6.26 today, likely seeing profit-taking following last week's sector-driven rebound. • No fresh...
🟢 Eupraxia Pharmaceuticals is trading 5% up today on broader healthcare sector rotation
Eupraxia Pharmaceuticals is trading 5% up today at $6.47, rebounding from yesterday’s 5.5% drop as investors shift into defensive healthcare names. • The move...
🔴 Eupraxia Pharmaceuticals is trading 5.1% down today amid broader market weakness
Eupraxia Pharmaceuticals is trading 5.1% down at $6.34 today as broader market weakness and risk-off sentiment weigh on the stock. • Shares are retracing...
🟢 Eupraxia Pharmaceuticals is trading 5.6% up today on sustained bullish analyst coverage and financing momentum
Eupraxia Pharmaceuticals is trading at $7.30 (5.6% up) in pre-market as investors respond to a wave of positive analyst coverage and recent financing...
🟢 Eupraxia Pharmaceuticals is trading 5.5% up today, extending a multi-day rebound following bullish analyst coverage
Eupraxia Pharmaceuticals is trading at $7.30 (5.5% up) in pre-market, extending its multi-day rebound from late June levels as investors react to sustained...
🟢 EPRX is trading 7.4% up today as Eupraxia Pharmaceuticals appoints three new directors to its Board
• Eupraxia Pharmaceuticals (NASDAQ:EPRX) announced today the appointment of Robert Bazemore, Amy Pott, and Dr. Helen Thackray to its Board of Directors. • The...
🟢 EPRX is trading 5.8% up today on continued biotech sector momentum
EPRX is trading at $6.97 (5.8% up) in pre-market, extending strength seen during the recent biotech-led rally. • The move appears tied to continued positive...
🟢 EPRX is trading 14.7% up today on bullish biotech sentiment and risk-on market moves
EPRX is trading at $7.56 (14.7% up) in after-hours trading, extending strong gains from the regular session amid a broader rally in biotechnology stocks. •...
🟢 EPRX is trading 10.5% up today with no clear company-specific catalyst found
EPRX is trading at $7.30 (10.54% up) in pre-market action despite a lack of major company-specific announcements, earnings releases, or regulatory updates to...
🟢 Eupraxia Pharmaceuticals Inc. is trading 10.88% up in pre-market
EPRX is trading at $6.93, up 10.88% in pre-market.
🔴 EPRX is trading 5.3% down today amid broader risk-off sentiment
EPRX is trading 5.3% down at $6.29 today, pulling back alongside other growth and tech-related names amid a broader risk-off market tone. • The decline...